- Home
- MTVA vs BOF Comparison
MTVA vs BOF Comparison
Compare MTVA & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- BOF
- Stock Information
- Founded
- MTVA 2014
- BOF 2017
- Country
- MTVA United States
- BOF United States
- Employees
- MTVA N/A
- BOF N/A
- Industry
- MTVA
- BOF Packaged Foods
- Sector
- MTVA
- BOF Consumer Staples
- Exchange
- MTVA NYSE
- BOF Nasdaq
- Market Cap
- MTVA 16.8M
- BOF 15.1M
- IPO Year
- MTVA N/A
- BOF 2023
- Fundamental
- Price
- MTVA $1.60
- BOF $1.91
- Analyst Decision
- MTVA Strong Buy
- BOF
- Analyst Count
- MTVA 1
- BOF 0
- Target Price
- MTVA $12.00
- BOF N/A
- AVG Volume (30 Days)
- MTVA 23.0K
- BOF 140.5K
- Earning Date
- MTVA 03-27-2025
- BOF 04-01-2025
- Dividend Yield
- MTVA N/A
- BOF N/A
- EPS Growth
- MTVA N/A
- BOF N/A
- EPS
- MTVA N/A
- BOF N/A
- Revenue
- MTVA N/A
- BOF $6,489,951.00
- Revenue This Year
- MTVA N/A
- BOF N/A
- Revenue Next Year
- MTVA N/A
- BOF N/A
- P/E Ratio
- MTVA N/A
- BOF N/A
- Revenue Growth
- MTVA N/A
- BOF 372.36
- 52 Week Low
- MTVA $1.51
- BOF $0.61
- 52 Week High
- MTVA $6.75
- BOF $4.11
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- BOF 39.91
- Support Level
- MTVA N/A
- BOF $2.40
- Resistance Level
- MTVA N/A
- BOF $2.59
- Average True Range (ATR)
- MTVA 0.00
- BOF 0.20
- MACD
- MTVA 0.00
- BOF -0.08
- Stochastic Oscillator
- MTVA 0.00
- BOF 7.50
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.